IL6 and ulcerative colitis: Since IL-1β, IL-6 and TL1A are all capable of inducing IL-22 production, it is possible that pathway redundancy and IL-23-independent induction of IL-22 might contribute to ustekinumab resistance in ulcerative colitis.